Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134721) titled 'Randomized, Controlled, Blinded Clinical Study of Graphene FarInfrared Cap for Symptom Improvement in Depressive Disorder (SingleCenter Exploratory Trial)' on Oct. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiamen Xianyue Hospital
Condition:
Depression disorder
Intervention:
Group A: True Treatment Cap Group:Receive graphene far-infrared cap intervention. Initial wearing training completed at hospital, followed by home use. 60 minutes per session, 2 times daily, 7 days weekly, for at least 6 weeks.
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2...